Cargando…

Targeting cytokine storm in COVID-19: what have we learned?

Detalles Bibliográficos
Autor principal:	Ridker, Paul M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Invited Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344880/ https://www.ncbi.nlm.nih.gov/pubmed/35919093 http://dx.doi.org/10.1093/ehjopen/oeab005

Ejemplares similares

What we learned from STEP that we didn't already know from SPRINT
por: Modesti, Pietro Amedeo
Publicado: (2021)

Cytokine Storms in Cancer and COVID-19
por: Turnquist, Casmir, et al.
Publicado: (2020)

The gathering storm
por: O’Donnell, Thomas F.
Publicado: (2022)

Same storm, different boat: The global impact of COVID‐19 on palliative care
por: Willis, Kelcie D., et al.
Publicado: (2022)

COVID-19 and patient engagement in health research: What have we learned?
por: Denegri, Simon, et al.
Publicado: (2021)

Advancing global change biology through experimental manipulations: Where have we been and where might we go?
por: Hanson, Paul J., et al.
Publicado: (2019)

The effect of ramatroban on cytokine and thrombotic storms in Covid-19
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

The (pro)renin receptor. A decade of research: what have we learned?
por: Krop, Manne, et al.
Publicado: (2012)

Colorectal screening: We have not caught up. A surge of colorectal cancer after the coronavirus disease 2019 (COVID-19) pandemic?
por: Challine, Alexandre, et al.
Publicado: (2021)

COVID-19: more than a cytokine storm
por: Riva, Giovanni, et al.
Publicado: (2020)

A glimpse into the eye of the COVID-19 cytokine storm
por: Kuppalli, Krutika, et al.
Publicado: (2020)

The COVID-19 Cytokine Storm; What We Know So Far
por: Ragab, Dina, et al.
Publicado: (2020)

What We Talk About When We Talk About Training in Endoscopic Sleeve Gastroplasty
por: Hadi, Yousaf, et al.
Publicado: (2023)

Vaginal mesh: What lessons have we learnt?
por: Robinson, Dudley, et al.
Publicado: (2020)

Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?
por: Mathebula, Lindi, et al.
Publicado: (2022)

Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
por: Chen, Luke Y.C., et al.
Publicado: (2021)

Gene expression in human sepsis: what have we learned?
por: Russell, James A
Publicado: (2011)

Violence against children in the time of COVID-19: What we have learned, what remains unknown and the opportunities that lie ahead
por: Fore, Henrietta H.
Publicado: (2021)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

We need to talk about Covid-19 pandemic related stress
por: Obeng-Gyasi, Samilia
Publicado: (2022)

Are all cytokine storms the same?
por: Panoskaltsis, Nicki
Publicado: (2021)

Covid-19 and drug therapy, what we learned
por: Provenzani, Alessio, et al.
Publicado: (2020)

Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021)

Extended lymph node dissection for intermediate and high-risk prostate cancer: do we have all the evidence?
por: Ghazi, Ahmed
Publicado: (2015)

What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014)

Multisystem inflammatory syndrome in children and complete atrioventricular block: What have we learned so far and where do we go from here?
por: Clark, Bradley C, et al.
Publicado: (2021)

Nutrition in the management of peripheral arterial disease: should we pay more attention to what our patients eat?
por: Audu, Christopher O., et al.
Publicado: (2021)

Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
por: Panigrahy, Dipak, et al.
Publicado: (2020)

Educational and Training Lessons from the COVID-19 Pandemic: We Must Prepare for the Next Pandemic
por: Sharp, Kenneth W.
Publicado: (2020)

Coronavirus Disease 2019 and Acute Kidney Injury: What Have We Learned?
por: Husain-Syed, Faeq, et al.
Publicado: (2021)

History of gestational diabetes and future cardiovascular disease: What have we learned?
por: Hsu, Cherng‐Lan, et al.
Publicado: (2018)

What will we choose to learn from the COVID-19 pandemic?
por: Bayingana, Alice Uwase, et al.
Publicado: (2021)

Hydrocephalus treatment and outcome in African infants with myelomeningocele: what we have learned so far
por: Warf, Benjamin C
Publicado: (2010)

COVID 19: Have we nailed it?
por: Gogia, Atul
Publicado: (2021)

What we have learned from the European Heart Rhythm Association consensus document on device-detected subclinical atrial tachyarrhythmias
por: Özcan, Emin Evren, et al.
Publicado: (2018)

Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
por: Camaradou, Jennifer Catherine Louise, et al.
Publicado: (2023)

Proximal tubular dysfunction in patients with COVID-19: what have we learnt so far?
por: Braun, Fabian, et al.
Publicado: (2020)

COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021)

COVID-19: what have we learned?
por: Ho, Yeh-Li, et al.
Publicado: (2020)

COVID-19: What have we learned?
por: Rafalowski, Chaim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q5o4hen3jvi6vvc3q0vgs4nkos